Adamas Finance Asia Limited New Investment (0068I)

TIDMADAM

RNS Number : 0068I

Adamas Finance Asia Limited

19 March 2018

ADAMAS FINANCE ASIA LIMITED

("ADAM" or the "Group")

NEW INVESTMENT

First Investment made by the New Manager

Adamas Finance Asia Limited ("ADAM"), the London quoted pan-Asian diversified investment vehicle, is pleased to announce its investment in a new project, DocDoc Pte. Ltd. ("DocDoc"). The investment is in line with ADAM's revised strategy, following the appointment of Harmony Capital as the new manager in May 2017, which aims to provide investors with a diverse portfolio of pan-Asian income producing assets with capital gain potential.

The Directors believe that DocDoc is Asia's leading patient empowerment company. The company leverages proprietary data and clinical informatics across a network of physicians and hospitals to support patients to find high quality medical care. Headquartered in Singapore, DocDoc connects and represents an extensive healthcare network with over 23,000 physicians, 700 clinics and 100 hospitals. DocDoc addresses a significant unmet need in the marketplace for patient empowerment, resulting in efficiently priced treatments, better outcomes and improved experiences for patients across Asia.

The benefits of DocDoc's proprietary database, algorithms and data models, combined with its business and customer service processes, are beneficially impacting an underserved need in the health insurance sector as evidenced by the execution of agreements with several of the leading insurers in the region.

ADAM was the lead investor in DocDoc's latest US$5.45M round of investment via a US$2.0M subscription to a convertible bond offering.

ADAM's Chairman, John Croft, commented on the new investment:

"We are delighted to make our first investment following the change to our investment policy and a series of disposals in 2017. The transformation of the ADAM portfolio is underway and the DocDoc investment represents an important step in reshaping the portfolio. DocDoc is an exciting next generation digital health platform, adeptly fulfilling patient demand and supported by partnerships with leading players such as the Ping An Group and Prudential."

DocDoc's Co-Founder and CEO, Cole Sirucek, commented on the new investment:

"We are thrilled to welcome ADAM to the DocDoc family. Their investment has come at a most opportune time as we scale our value-added doctor discovery service in conjunction with the region's largest insurance companies. The ADAM and Harmony Capital team have done a great job helping us put this financing together and we look forward to them adding significant value going forward."

Enquiries:

 
 Adamas Finance Asia 
  Limited                      +44 (0) 1825 
  John Croft                         830587 
  WH Ireland Limited - 
   Nominated Adviser 
   Tim Feather                  +44 (0) 113 
   James Sinclair-Ford             394 6600 
  finnCap Limited - Broker 
   William Marle                 +44 (0) 20 
   Grant Bergman                  7220 0500 
 Buchanan - Financial 
  PR 
  Charles Ryland                 +44 (0) 20 
  Henry Wilson                    7466 5000 
 

About Adamas Finance Asia

ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes.

The company's investment manager, Harmony Capital, which has a dedicated team with real Asian expertise, will focus on the strategy of creating income and capital growth. Harmony is sourcing predominately private opportunities and has created a strong pipeline. Income generating assets include investments in property, mining, pharmaceuticals, and telecoms across Asia.

About DocDoc

DocDoc is Asia's leading patient empowerment company. Operating in 8 countries with more than 23,000 doctors, DocDoc enables patients to find the right care at the right time. The company combines deep expertise in clinical informatics, artificial intelligence and healthcare quality assessment to deliver simple yet powerful patient solutions.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSFAFFMFASEDD

(END) Dow Jones Newswires

March 19, 2018 03:00 ET (07:00 GMT)